Altrinsic Global Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-151,282
| Closed | -$12.1M | – | 46 |
|
|
2024
Q1 | $12.1M | Sell |
151,282
-11,134
| -7% | -$888K | 0.54% | 24 |
|
|
2023
Q4 | $12.8M | Sell |
162,416
-65,731
| -29% | -$5.19M | 0.54% | 24 |
|
|
2023
Q3 | $15.9M | Sell |
228,147
-12,371
| -5% | -$864K | 0.61% | 25 |
|
|
2023
Q2 | $16.6M | Sell |
240,518
-11,086
| -4% | -$766K | 0.64% | 26 |
|
|
2023
Q1 | $18.7M | Buy |
251,604
+48,183
| +24% | +$3.58M | 0.72% | 24 |
|
|
2022
Q4 | $19M | Sell |
203,421
-9,195
| -4% | -$857K | 0.81% | 22 |
|
|
2022
Q3 | $20.3M | Sell |
212,616
-1,729
| -0.8% | -$165K | 0.93% | 20 |
|
|
2022
Q2 | $19.9M | Sell |
214,345
-12,920
| -6% | -$1.2M | 0.81% | 24 |
|
|
2022
Q1 | $23M | Sell |
227,265
-143,031
| -39% | -$14.5M | 0.8% | 23 |
|
|
2021
Q4 | $38.2M | Sell |
370,296
-68,789
| -16% | -$7.1M | 1.22% | 19 |
|
|
2021
Q3 | $37.3M | Buy |
439,085
+54,963
| +14% | +$4.66M | 1.12% | 25 |
|
|
2021
Q2 | $32.1M | Sell |
384,122
-215
| -0.1% | -$17.9K | 0.97% | 30 |
|
|
2021
Q1 | $28.9M | Buy |
384,337
+7,785
| +2% | +$586K | 0.91% | 32 |
|
|
2020
Q4 | $25.7M | Sell |
376,552
-1,339
| -0.4% | -$91.5K | 0.87% | 29 |
|
|
2020
Q3 | $22.1M | Buy |
377,891
+3,502
| +0.9% | +$205K | 0.9% | 29 |
|
|
2020
Q2 | $24.3M | Sell |
374,389
-8,867
| -2% | -$576K | 1.06% | 27 |
|
|
2020
Q1 | $22.7M | Buy |
383,256
+22,148
| +6% | +$1.31M | 1.25% | 26 |
|
|
2019
Q4 | $26.8M | Sell |
361,108
-24,952
| -6% | -$1.85M | 1.13% | 28 |
|
|
2019
Q3 | $24.3M | Buy |
386,060
+38,617
| +11% | +$2.44M | 1.05% | 28 |
|
|
2019
Q2 | $18.9M | Sell |
347,443
-9,098
| -3% | -$496K | 0.88% | 30 |
|
|
2019
Q1 | $19.2M | Buy |
356,541
+94,300
| +36% | +$5.09M | 0.89% | 33 |
|
|
2018
Q4 | $17.2M | Buy |
262,241
+7,315
| +3% | +$479K | 0.82% | 35 |
|
|
2018
Q3 | $20.1M | Buy |
254,926
+191,926
| +305% | +$15.1M | 0.91% | 34 |
|
|
2018
Q2 | $4.05M | Buy |
+63,000
| New | +$4.05M | 0.16% | 54 |
|